BPC-157 & TB-500 Blend Research-Grade Synergistic Tissue Repair Blend

Product Overview

The BPC-157 and TB-500 blend is a highly advanced, dual-peptide formulation designed for comprehensive in vitro and animal model studies focusing on accelerated wound healing, tissue regeneration, and cytoprotection. By combining these two distinct compounds, researchers can observe the synergistic effects of targeting multiple physiological repair pathways simultaneously.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. It is heavily researched for its profound cytoprotective properties, its ability to significantly upregulate the Vascular Endothelial Growth Factor (VEGF) pathway to promote angiogenesis (the formation of new blood vessels), and its acceleration of tendon, ligament, and gastrointestinal tissue repair.

TB-500 is a synthetic analogue of the active region of Thymosin Beta-4, a naturally occurring, highly conserved actin-binding protein. Its primary mechanism of action in research models involves the upregulation of cellular actin, forming the structural matrix vital for cellular motility and migration. TB-500 effectively “guides” reparative cells to sites of injury while mitigating localized inflammation.

When combined, BPC-157 creates the necessary vascular infrastructure for repair, while TB-500 provides the cellular mobility and structural proteins required for rapid tissue regeneration.

Primary Research Applications

Under doctor-reviewed scientific literature, the combination of BPC-157 and TB-500 is frequently utilized in in vitro and animal model studies to observe:

• Synergistic Tissue Repair: Investigating the accelerated recovery of musculoskeletal tissues (tendons, ligaments, and muscle fibers) through dual-pathway activation.

• Angiogenesis & Cellular Migration: Observing the coordinated upregulation of blood vessel formation (BPC-157) alongside enhanced cellular motility and actin matrix formation (TB-500).

• Cytoprotection & Mucosal Healing: Tracking the repair of gastric and intestinal mucosa in models of NSAID-induced damage or inflammatory bowel conditions.

• Systemic Anti-Inflammatory Pathways: Measuring the dampening of acute and chronic inflammatory cascades at injury sites.

The BioRegen Standard

When you source your BPC-157 & TB-500 Blend from BioRegen Peptides, you are backed by our five core pillars of quality and service:

• Uncompromising Purity: Every batch is independently third-party tested to guarantee >99% purity and molecular integrity, ensuring your dual-pathway models are exact and uncontaminated.

• Doctor-Reviewed Accuracy: All product specifications and research handling guidelines are medically reviewed for absolute scientific accuracy.

• Unbeatable Value: Premium, verified research compounds at industry-disrupting prices.

• Fast, US-Based Shipping: Stocked physically in the USA to bypass customs delays and arrive at your lab in days.

• Dedicated Support: Have a question about a batch-specific COA? Email our US-based team at support@bioregenpeptides.com for a rapid response.

Product Specifications

• Nomenclature: BPC-157 (Pentadecapeptide) / TB-500 (Thymosin Beta-4 Analogue)

• Amino Acid Sequences: * BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

  • TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

• CAS Numbers: 137525-51-0 (BPC-157) / 77591-33-4 (TB-500)

• Purity: >99% (Verified via HPLC/MS for both compounds)

• Format: Lyophilized Powder

---

Regulatory Notice: This product is sold strictly for laboratory and research purposes only. It is not intended for human consumption, diagnostic, therapeutic, or prophylactic use. Please refer to our doctor-reviewed handling guidelines for proper research protocols.